国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Negotiators work to bring down nation's prescriptions

Public paying dramatically less for therapeutic drugs thanks to bulk-buy scheme

By WANG XIAOYU | China Daily | Updated: 2025-02-06 08:47
Share
Share - WeChat
A worker checks capsules on a production line in Liuyang, Hunan province, in June. CHEN SIHAN/XINHUA

Du Wentao, chairman of Yichang Humanwell Pharmaceutical, said during an interview with state broadcaster China Central Television that it has spent five years and over 70 million yuan in researching the drug.

"So far, our drugs have only been introduced to less than 20 percent of relevant hospitals and many parents have to travel far to larger hospitals to obtain the drug," he said. "Getting on the list means that grassroots coverage for the drug will be improved and more child patients can access effective treatment."

Wu Jing, deputy dean of Tianjin University's School of Pharmaceutical Science and Technology, said, "The speedy action related to boosting access to the drug has demonstrated the government's attention to the rare disease patient community."

Even though the market price of domestic Clobazam per tablet is only 3 yuan, Wu said that the medicine is usually delivered along with other drugs and the total costs constitute a heavy burden on some families.

"The price reduction could range from a few percent to over 90 percent because the principle is not purely chasing after steep cuts, but a pursuit of the most reasonable price," Wu said. "All negotiated prices will be tested against economic barometers that evaluate clinical value."

Huang, the official from the National Healthcare Security Administration, said that during price negotiations in late October, a total of 28 drugs failed to secure a deal. The reason was that their anticipated prices had exceeded the bottom-line price by a giant margin, and some drugmakers were unwilling to reduce their prices to a level lower than the international average.

Authorities were looking for the lowest price compared to the United States, the United Kingdom, Japan and other developed countries, which have a much higher GDP per capita compared to China. It is reasonable to ask for a lower price than these markets considering China's large population, Huang said.

|<< Previous 1 2 3 4 5 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
三明市| 南昌县| 墨竹工卡县| 萍乡市| 上杭县| 黄骅市| 兰州市| 通许县| 抚宁县| 九龙县| 蚌埠市| 镇巴县| 怀宁县| 精河县| 孝昌县| 长子县| 兴宁市| 客服| 肇庆市| 宝山区| 黔西| 老河口市| 高雄市| 竹溪县| 锦屏县| 宜兰县| 徐汇区| 慈利县| 岳普湖县| 新沂市| 宜阳县| 南宁市| 宜兰县| 永丰县| 安塞县| 达拉特旗| 那坡县| 旬阳县| 运城市| 娄底市| 纳雍县|